Integra LifeSciences (IART) Misses Q1 EPS by 1c, Beats on Revenue, In-Line Fy Guidance

Integra LifeSciences (NASDAQ: IART) reported Q1 EPS of $0.39, $0.01 worse than the analyst estimate of $0.40. Revenue for the quarter came in at $258.22 million versus the consensus estimate of $254.22 million.

GUIDANCE:

Integra LifeSciences sees FY2017 EPS of $1.88-$1.94, versus the consensus of $1.91. Integra LifeSciences sees FY2017 revenue of $1.12-1.14 billion, versus the consensus of $1.13 billion.

For earnings history and earnings-related data on Integra LifeSciences (IART) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance